Edition:
United Kingdom

People: Microport Scientific Corp (0853.HK)

0853.HK on Hong Kong Stock

6.20HKD
23 Aug 2019
Change (% chg)

HK$0.03 (+0.49%)
Prev Close
HK$6.17
Open
HK$6.18
Day's High
HK$6.28
Day's Low
HK$6.08
Volume
2,863,559
Avg. Vol
4,129,697
52-wk High
HK$11.50
52-wk Low
HK$5.21

Chen, Jonathan 

Mr. Jonathan Chen is Senior Vice President - International Operations & Investor Relations of MicroPort Scientific Corporation. Mr. Jonathan Chen has been with the Company since July 2012. Mr. Chen’s primary responsibilities include growing MicroPort’s International business in markets outside of China primarily in U.S., Europe and South America geographies. Mr. Chen has over 19 years’ experience in the medical devices industry. Prior to joining MicroPort, Mr. Chen worked for Angiotech Pharmaceuticals, Inc. for 6 years where he was Senior Vice President, Business Development where he led the management team to build a US$300 million in revenue medical products business through various acquisitions and licensing transactions. Prior to joining Angiotech, Mr. Chen was a life sciences investment banker for Credit Suisse and Alex. Brown & Sons where he helped his clients raise in excess of US$2 billion in equity and debt capital and advised on over US$3 billion in M&A transactions. Mr. Chen has a Bachelor of Arts in Economics and a Bachelor of Sciences with honors in Biological Sciences from Stanford University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhaohua Chang

205,000

Hongbin Sun

2,660,000

Junder Chiang

--

Jonathan Chen

--

Qiyi Luo

1,943,000

Wing Sze Chan

--
As Of  31 Dec 2014